MARINACCIO, Marco
 Distribuzione geografica
Continente #
NA - Nord America 3.487
AS - Asia 1.514
EU - Europa 1.441
SA - Sud America 343
AF - Africa 33
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.822
Nazione #
US - Stati Uniti d'America 3.440
SG - Singapore 692
CN - Cina 390
BR - Brasile 294
DE - Germania 270
IT - Italia 245
SE - Svezia 206
HK - Hong Kong 203
RU - Federazione Russa 193
UA - Ucraina 142
GB - Regno Unito 105
FI - Finlandia 93
VN - Vietnam 93
FR - Francia 83
IN - India 37
CA - Canada 25
BE - Belgio 20
AR - Argentina 17
MX - Messico 15
BD - Bangladesh 14
JP - Giappone 14
AT - Austria 12
NL - Olanda 12
PL - Polonia 12
ZA - Sudafrica 12
ID - Indonesia 10
IE - Irlanda 9
LT - Lituania 9
TR - Turchia 9
EC - Ecuador 8
ES - Italia 7
IQ - Iraq 7
KR - Corea 7
PK - Pakistan 6
PY - Paraguay 6
VE - Venezuela 6
IR - Iran 5
RO - Romania 5
AZ - Azerbaigian 4
CO - Colombia 4
JO - Giordania 4
MA - Marocco 4
AU - Australia 3
CI - Costa d'Avorio 3
CL - Cile 3
DK - Danimarca 3
EE - Estonia 3
KE - Kenya 3
PE - Perù 3
SA - Arabia Saudita 3
TH - Thailandia 3
TN - Tunisia 3
AE - Emirati Arabi Uniti 2
BG - Bulgaria 2
DZ - Algeria 2
EG - Egitto 2
JM - Giamaica 2
LY - Libia 2
MD - Moldavia 2
OM - Oman 2
AL - Albania 1
BB - Barbados 1
BO - Bolivia 1
BZ - Belize 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GE - Georgia 1
HU - Ungheria 1
KG - Kirghizistan 1
KW - Kuwait 1
LB - Libano 1
LC - Santa Lucia 1
LU - Lussemburgo 1
LV - Lettonia 1
MY - Malesia 1
NG - Nigeria 1
NO - Norvegia 1
NP - Nepal 1
PH - Filippine 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
TT - Trinidad e Tobago 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.822
Città #
Singapore 355
Ashburn 341
Fairfield 328
Chandler 323
Woodbridge 307
Jacksonville 264
Hong Kong 199
Houston 188
Nyköping 175
Ann Arbor 168
Wilmington 131
Seattle 124
Beijing 120
Cambridge 118
Nanjing 80
Lawrence 70
Roxbury 70
New York 59
Los Angeles 50
Boardman 45
Des Moines 44
Dallas 43
Bari 37
Ho Chi Minh City 31
Inglewood 31
São Paulo 30
Princeton 29
Dearborn 26
Munich 25
Brussels 20
Buffalo 20
Moscow 20
San Diego 19
Hanoi 18
Hebei 18
Santa Clara 18
Helsinki 16
Shenyang 16
Brooklyn 14
Jiaxing 14
Changsha 13
London 13
Tokyo 12
Turku 12
Chennai 11
Frankfurt am Main 11
Montreal 11
Poplar 11
Warsaw 11
Chicago 10
Nanchang 10
Dublin 9
Orem 9
Boston 8
Council Bluffs 8
Guangzhou 8
Jakarta 8
San Francisco 8
Washington 8
Atlanta 7
Denver 7
Hefei 7
Johannesburg 7
Paris 7
Pescara 7
Toronto 7
Milan 6
Mumbai 6
Rio de Janeiro 6
Tianjin 6
Vienna 6
Ankara 5
Asunción 5
Nuremberg 5
San Jose 5
Wuhan 5
Amman 4
Amsterdam 4
Belo Horizonte 4
Biên Hòa 4
Catania 4
Cosenza 4
Da Nang 4
Dong Ket 4
Düsseldorf 4
Falls Church 4
Grottaglie 4
Lissone 4
Manaus 4
Matera 4
Mexico City 4
Norwalk 4
Phoenix 4
Porto Alegre 4
Portsmouth 4
Pune 4
Rome 4
Stockholm 4
The Dalles 4
Abidjan 3
Totale 4.394
Nome #
Valutazione dell'efficienza dello Sniff-test (test delle amine) nella diagnosi di infezione da Gardnerella Vaginalis 187
Higher prevalence of chronic endometritis in women with endometriosis: a possible etiopathogenetic link 172
Chronic Endometritis, a Common Disease Hidden Behind Endometrial Polyps in Premenopausal Women: First Evidence From a Case-Control Study. 171
Possible Inflammatory Origin of Endometrial Polyps 165
Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19) 148
A dominant ovarian follicle induces unilateral changes in the origin of the blood supply to the tubal corner of the uterus 147
NEOADJUVANT CHEMOTHERAPY (NACHT) FOR LOCALLY ADVANCED CERVICAL CANCER (LACC): OUR EXPERIENCE WITH TIP (TAXOL+IFOSFAMIDE+PLATINUM) REGIMEN 140
Gastrointestinal stromal tumors mimicking gynecological masses on ultrasound: a report of two cases 137
Chronic endometritis due to common bacteria is prevalent in women with recurrent miscarriage as confirmed by improved pregnancy outcome after antibiotic treatment. 128
Alexithymia, Immunity and Cervical Intraepithelial Neoplasia: Replication 127
"L'associazione Mitoxantrone intraperitoneale e Timopentina come terapia dell'ascite ricorrente nel carcinoma ovarico". 124
Beyond BRCA1/2: Homologous Recombination Repair Genetic Profile in a Large Cohort of Apulian Ovarian Cancers 123
Detection of chronic endometritis at fluid hysteroscopy 122
Chronic Endometritis Due to Common Bacteria Is Prevalent in Women With Recurrent Miscarriage as Confirmed by Improved Pregnancy Outcome After Antibiotic Treatment 122
Alexithymia, Immunity and Cervical Intraepithelial Neoplasia: A Pilot Study 121
Pregnancy related cancer in Apulia. A population based linkage study. 121
Hysteroscopic diagnosis and treatment of endocervical ossification: a case report 119
Long-term follow-up is crucial after treatment for granulosa cell tumours of the ovary 114
Intraperitoneal mitoxantrone in the treatment of recurrent ascites from progressive epithelial ovarian cancer 113
Serum half life of CA 72.4 during adjuvant chemotherapy for ovarian cancer 112
Microbiological findings in endometrial specimen: our experience 112
Second-Line Chemotherapy in Recurrent Clear Cell Ovarian Cancer: Results from the Multicenter Italian Trials in Ovarian Cancer (MITO-9). 109
Enhanced osteoclastogenesis in women after natural delivery 107
Failure of CA72.4 in early detection of recurrent ovarian cancer 106
Gemcitabina in monochemioterapia nella terapia di salvataggio del carcinoma ovarico platino-taxol resistente 103
Phase II study of weekly topotecan in recurrent ovarian cancer: duration of response based on a prolonged follow-up 103
Predictive factors for pain experienced at office fluid minihysteroscopy 96
Reliability of diagnostic fluid hysteroscopy in the assessment of cervical invasion by endometrial carcinoma:a a comparative study with transvaginal sonography and MRI 96
"I nuovi parametri ematologici valutati nella gravidanza a termine. Nota II: Ampiezza della distribuzione piastrinica (PDW)”. 96
Primary surgical cytoreduction in advanced ovarian cancer: An outcome analysis within the MITO (Multicentre Italian Trials in Ovarian Cancer and Gynecologic Malignancies) Group 94
Residual neurotoxicity in ovarian cancer patients in clinical remission after first-line chemotherapy with carboplatin and paclitaxel:the Multicenter Italian Trial in Ovarian Cancer (MITO-4) retrospective study 93
Uterine cavity findings at fluid mini-hysteroscopy in patients with no evidence of uterine cavity abnormality at TVE who repeatedly failed to conceive at IVF. 92
Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: A multicentre MITO retrospective study 92
Ovarian Sertoli-Leydig cell tumors. A retrospective MITO study 90
Pretreatment serum hemoglobin as a prognostic factor in epithelial ovarian cancer 88
Trabectedin as single agent in the salvage treatment of heavily treated ovarian cancer patients: A retrospective, multicenter study 87
IS THERE STILL AN AVOIDABLE FRACTION OF POSTOPERATIVE THROMBOEMBOLIC COMPLICATIONS WITH HEPARIN-PROPHYLAXIS - THE RESULTS OF A CASE-CONTROL SURVEILLANCE 87
Neoplasie ginecologiche in pazienti con epatopatia cronica. III Carcinoma della Cervice 85
Infezione da Gardnerella Vaginalis e contraccezione 83
Mioma uterino gigante: descrizione di un caso e revisione della letteratura 81
Histerostopic diagnosis and treatment of endocervical ossification: a case report 81
An Extremely Rare Case of Disseminated Peritoneal Leiomyomatosis with a Pelvic Leiomyosarcoma and Omental Metastasis after Laparoscopic Morcellation: Systematic Review of the Literature 80
Ebstein's anomaly 80
Risk groups and adjuvant therapy in surgical stated endometrial cancer patients.A randomized multicentre study comparing chemotherapy with radiation therapy 77
PRIMARY FALLOPIAN TUBE CARCINOMA : ANALYSIS OF 25 PATIENTS 75
“Failure of CA 72.4 to detect asymptomatic recurrent ovarian carcinoma.” 75
Approccio psicologico al cancro. Risultati preliminari di una ricerca su cancro e fattori di personalità 73
I nuovi parametri ematologici valutati nella gravidanza a termine. Nota I: Ampiezza della distribuzione eritrocitaria (RDW) 73
Paclitaxel, ifosfamide, and cisplatin regimen as neoadjuvant chemotherapy in young women with locally advanced squamous cervical cancer 72
Cervical Intraepithelial Neoplasia: a psycho-immunological outlook 70
Pretreatment normalization of mild anemia with epoietin alfa predicts long-term outcome for women with epithelial ovarian cancer 69
Whose surgery is this? Endometriosis of the round ligament 66
Il controllo dell'ascite ricorrente secondaria a carcinoma ovarico in ricaduta con mitoxantrone intraperitoneale 66
Oral etoposide as a salvage therapy in recurrent epithelial ovarian cancer 65
High prevalence of chronic endometritis in women with nonstructural abnormal uterine bleeding and benefits of antimicrobial treatment on blood loss pattern: A prospective, observational study 64
Trabectidin as single-agent in heavily pretreated patients with relapsed ovarian cancer (ROC): results from a retrospective study 64
Weekly topotecan as a salvage-therapy in heavily pre-treated patients with recurrent platinum-resistant epithelial ovarian cancer 61
Pclitaxel, ifosfamide, and Cisplatin regimen as neoadjuvat chemotherapy in young women with locally advanced squamous cervical cancer 61
Mesotelioma multicistico del peritoneo. Scattone A, Pennella A, Marinaccio M, Lonigro G, Ricco R, Pollice L, Serio G 59
Surgical and Medical Treatment of Clear Cell Ovarian Cancer: Results From the Multicenter Italian Trials in Ovarian Cancer (MITO) 9 Retrospective Study 59
The value of CA125 in the diagnosis of adenomyosis 57
TIP (Taxol, Ifosfamide, Cisplatin) regimen as neoadjuvant chemotherapy in young women with locally advanced squamous cervical cancer 57
Serum beta 2-microglobulin as a prognostic indicator in epithelial ovarian cancer 57
Rapporti tra alexitimia, espressioni linfocitarie e displasie (CIN) della cervice uterina 57
Utilizzo di criteri sonoembriologici nella valutazione dell'età gestazionale 56
Topotecan compared with no therapy afetr response to surgery and Carboplatin/Paclitaxel in patients with ovarian cancer.MITO-1 randomized study 56
Il trattamento delle infezioni ginecologiche: confronto tra Carumonam + Piperacillina versus Aztreonam + Piperacillina. 53
Surgical and medical treatment of clear cell ovarian cancer: results from the Multicenter Ovarian Trial (Mito )9 restrospective study 52
Upgrading Treatment and Molecular Diagnosis in Endometrial Cancer-Driving New Tools for Endometrial Preservation? 50
Leuprolide acetate as a salvage-therapy in relapsed epithelial ovarian cancer. 50
Chronic Endometritis in Infertile Women: Impact of Untreated Disease, Plasma Cell Count and Antibiotic Therapy on IVF Outcome-A Systematic Review and Meta-Analysis 50
Rapporti tra cervicodisplasie, linfocitogramma periferico e alessitamia. Studio in fase II. 48
Serum progesterone, estradiol-17 beta and testosterone at the time of relapse in patients with epithelial ovarian cancer 46
Sonoembryological criteria in the evaluation of gestational age 46
Vulvar Malignant Melanoma: A Narrative Review 46
Pregnancy and fetal outcome in women with personal anamnesis of neoplasia treated with chemotherapy: A study on 29 cases 41
Pretreatment normalization of mild anemia with epoietin alfa: impact on the outcome in epithelial ovarian cancer 37
Stage I juvenile granulosa cell tumors of the ovary: A multicentre analysis from the MITO-9 study 27
Herlyn-Werner-Wunderlich associated hematometra mimicking endometrioid neoformation: A rare case report 24
A Normally Carried to Term Pregnancy with a Intrauterine Device (IUD) in Place: Not a Mission Impossible 20
Case Report: Advanced colorectal cancer diagnosed and treated with chemotherapy during pregnancy 2
Totale 6.935
Categoria #
all - tutte 29.121
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.121


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021397 0 0 0 0 0 40 74 40 66 79 62 36
2021/2022481 20 71 11 47 16 13 15 46 19 19 100 104
2022/2023834 107 79 66 84 116 121 8 76 145 4 11 17
2023/2024267 32 58 14 14 21 62 3 6 12 12 6 27
2024/20251.252 31 17 109 46 24 93 107 108 43 78 171 425
2025/20261.443 409 141 149 342 343 59 0 0 0 0 0 0
Totale 6.935